Interleukin-6 and the determinants of severe COVID-19: A retrospective cohort study

Wael Hafez1,2, Prashant Nasa3, Ahmed Khairy1

  • 1Internal Medicine, NMC Royal Hospital, Khalifa City, Abu Dhabi, United Arab Emirates.

Medicine
|November 14, 2023
PubMed

Insights

Elevated interleukin-6 (IL-6) levels correlate with severe COVID-19 and increased mortality risk. Understanding IL-6 and patient characteristics aids in predicting severe disease and guiding early treatment strategies for coronavirus disease 2019.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Severe COVID-19 is linked to elevated cytokine levels, particularly interleukin-6 (IL-6).
  • High IL-6 levels may indicate a heightened immune response, potentially leading to organ failure or death.
  • Predicting COVID-19 severity and patient outcomes is crucial for timely therapeutic interventions.

Purpose of the Study:

  • To investigate the association between serum IL-6 levels and COVID-19 severity.
  • To examine demographic, clinical, and biochemical factors related to IL-6 levels and disease severity.
  • To identify predictors of severe COVID-19 for early intervention strategies.

Main Methods:

  • A cohort study of 374 COVID-19 inpatients was conducted between November 2020 and November 2021.
  • Serum IL-6 levels, demographic data, clinical characteristics, and biochemical markers were analyzed.
  • Statistical analyses, including univariate and multivariate analyses, were performed to assess associations.

Main Results:

  • The elderly population showed a higher risk for severe COVID-19.
  • Higher levels of white blood cells, D-dimer, lactate dehydrogenase, creatinine, ferritin, prothrombin time, procalcitonin, and fibrinogen were observed in severe cases.
  • While univariate analysis showed associations between higher IL-6 and C-reactive protein, troponin, ICU admission, severity score, and mortality, these did not persist in multivariate analysis.

Conclusions:

  • Serum IL-6 levels, alongside demographic and clinical variables, influence COVID-19 severity.
  • Identifying patients at risk for severe disease is possible through analysis of these characteristics.
  • Further large-scale research is warranted to elucidate the role of IL-6 in COVID-19 outcomes.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.9K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K